Health Minister Mark Butler says the Therapeutic Goods Administration is considering an application from drug maker Moderna to allow its vaccines to be given to children aged from six months to five years old.
“If it is approved by the TGA that will then go to our advisory group on vaccines to consider the way in which this should be rolled out to the community, so I’d expect it to be a matter of some weeks,” Butler said on Tuesday.
Earlier, Butler told ABC radio it would be “unthinkable” not to hold a royal commission into the nation’s pandemic response.
“The amount of money spent, the death, the dislocation. We know a very long tail of mental and physical distress will be coming our way over the next couple of years,” he said.
“It would be unthinkable not to have a very deep look at how we responded to that and learn the lessons.”
He said any inquiry needed to be carried out over the next three years.
Meanwhile, Australians will have access to a single vaccine for COVID-19 and influenza by 2024 as clinical trials are set to begin.
The combined shot for flu, COVID-19 and respiratory virus RSV was in the early testing stages, with trials to start later this year, Moderna chief medical officer Paul Burton said.
Dr Burton expects combined vaccines will be key to fighting respiratory diseases in the aftermath of the pandemic, and to adapting to multiple strains within one season.
He said bringing vaccines together and adapting would be the future as the world considered diseases other than COVID-19.
Meanwhile, Australia’s multibillion-dollar mRNA manufacturing hub will be bigger than initially expected.
The first of its kind in the southern hemisphere, the facility was announced in March by the Morrison government as part of an agreement with Moderna.
Finding a location had reached its final stages and a site would be announced in a few weeks, Moderna Australia general manager Michael Azrak said.
“It’s taken a little bit longer than we anticipated because we’re actually going to be building a larger facility than we anticipated,” he said.
The pharmaceutical giant aimed to break ground on the Victorian site before the end of the year and to be operating by the end of 2024, subject to approval by the medicines regulator.
Local News Matters
Media diversity is under threat in Australia – nowhere more so than in South Australia. The state needs more than one voice to guide it forward and you can help with a donation of any size to InDaily. Your contribution goes directly to helping our journalists uncover the facts. Please click below to help InDaily continue to uncover the facts.